Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GLIDE
- Development stage
- Unknown
- Lead developer
- Glide Pharmaceutical Technologies
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
GLIDE is a hemp-derived wellness product developed by The Bombay Company (also known as BOHECO - Bombay Hemp Company) for the management of arthritis and joint pain. It is a proprietary Ayurvedic formulation that contains full-spectrum cannabinoids derived from Vijaya (*Cannabis sativa*) leaf extract and hemp seed oil as its active ingredients. The product is designed to interact with the body's Endocannabinoid System (ECS), specifically targeting CB2 receptors on immune cells to modulate inflammatory responses and reduce swelling and pain associated with osteoarthritis and rheumatoid arthritis. Additionally, the hemp seed oil component provides essential omega-3 and omega-6 fatty acids that assist in joint lubrication and improved mobility. GLIDE is available in multiple formats, including topical oils, gels, and oral capsules, and is approved by the state AYUSH Department in India as a natural alternative for arthritis management.
- Brand names
- GLIDE
- Other names
- BOHECO GLIDE
02
Targets
CB (Cannabinoid receptors)
Beyond the preview
Go deeper on GLIDE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GLIDE.